BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19187445)

  • 1. Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.
    Buccinnà B; Piccinini M; Prinetti A; Scandroglio F; Prioni S; Valsecchi M; Votta B; Grifoni S; Lupino E; Ramondetti C; Schuchman EH; Giordana MT; Sonnino S; Rinaudo MT
    J Neurochem; 2009 Apr; 109(1):105-15. PubMed ID: 19187445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
    Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
    Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration.
    Macauley SL; Sidman RL; Schuchman EH; Taksir T; Stewart GR
    Exp Neurol; 2008 Dec; 214(2):181-92. PubMed ID: 18778708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.
    Ledesma MD; Prinetti A; Sonnino S; Schuchman EH
    J Neurochem; 2011 Mar; 116(5):779-88. PubMed ID: 21214563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurons regulate the esterification of bioactive lipid mediators in the brain of acid sphingomyelinase deficient mice.
    Taha AY; Gaudioso Á; Moran-Garrido M; Camunas-Alberca SM; Bachiller-Hernández J; Sáiz J; Ledesma MD; Barbas C
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110896. PubMed ID: 37956788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Macrophage Function Associated with Crystalline Lung Inflammation in Acid Sphingomyelinase Deficiency.
    Poczobutt JM; Mikosz AM; Poirier C; Beatman EL; Serban KA; Gally F; Cao D; McCubbrey AL; Cornell CF; Schweitzer KS; Berdyshev EV; Bronova IA; Paris F; Petrache I
    Am J Respir Cell Mol Biol; 2021 May; 64(5):629-640. PubMed ID: 33662226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection of mouse and human neural stem cells into neonatal Niemann-Pick A model mice.
    Sidman RL; Li J; Stewart GR; Clarke J; Yang W; Snyder EY; Shihabuddin LS
    Brain Res; 2007 Apr; 1140():195-204. PubMed ID: 17289003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease.
    Pérez-Cañamás A; Benvegnù S; Rueda CB; Rábano A; Satrústegui J; Ledesma MD
    Mol Psychiatry; 2017 May; 22(5):711-723. PubMed ID: 27620840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase--deficient mouse model of Niemann-Pick disease.
    Dhami R; He X; Gordon RE; Schuchman EH
    Lab Invest; 2001 Jul; 81(7):987-99. PubMed ID: 11454988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology.
    Miranda SR; He X; Simonaro CM; Gatt S; Dagan A; Desnick RJ; Schuchman EH
    FASEB J; 2000 Oct; 14(13):1988-95. PubMed ID: 11023983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease.
    Ikegami M; Dhami R; Schuchman EH
    Am J Physiol Lung Cell Mol Physiol; 2003 Mar; 284(3):L518-25. PubMed ID: 12495943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders.
    Gabandé-Rodríguez E; Pérez-Cañamás A; Soto-Huelin B; Mitroi DN; Sánchez-Redondo S; Martínez-Sáez E; Venero C; Peinado H; Ledesma MD
    EMBO J; 2019 Jan; 38(2):. PubMed ID: 30530526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann-Pick A mouse.
    Yang WW; Dodge JC; Passini MA; Taksir TV; Griffiths D; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2007 Oct; 207(2):258-66. PubMed ID: 17686472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannose 6-phosphate receptor-mediated uptake is defective in acid sphingomyelinase-deficient macrophages: implications for Niemann-Pick disease enzyme replacement therapy.
    Dhami R; Schuchman EH
    J Biol Chem; 2004 Jan; 279(2):1526-32. PubMed ID: 14557264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation in acid sphingomyelinase-deficient mice: engraftment and cell migration into the brain as a function of radiation, age, and phenotype.
    Miranda SR; Erlich S; Visser JW; Gatt S; Dagan A; Friedrich VL; Schuchman EH
    Blood; 1997 Jul; 90(1):444-52. PubMed ID: 9207482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice.
    Scandroglio F; Venkata JK; Loberto N; Prioni S; Schuchman EH; Chigorno V; Prinetti A; Sonnino S
    J Neurochem; 2008 Oct; 107(2):329-38. PubMed ID: 18673449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice.
    Dhami R; Passini MA; Schuchman EH
    Mol Ther; 2006 Mar; 13(3):556-64. PubMed ID: 16214420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics.
    Murray JM; Thompson AM; Vitsky A; Hawes M; Chuang WL; Pacheco J; Wilson S; McPherson JM; Thurberg BL; Karey KP; Andrews L
    Mol Genet Metab; 2015 Feb; 114(2):217-25. PubMed ID: 25092414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of biochemical and behavioral defects in the Niemann-Pick type A mouse by intraventricular infusion of MARCKS.
    Trovò L; Stroobants S; D'Hooge R; Ledesma MD; Dotti CG
    Neurobiol Dis; 2015 Jan; 73():319-26. PubMed ID: 25251606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency.
    Gaudioso Á; Moreno-Huguet P; Casas J; Schuchman EH; Ledesma MD
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.